CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+5.12%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$5.78B
AUM Growth
+$56.1M
(+0.98%)
Cap. Flow
-$211M
Cap. Flow
% of AUM
-3.66%
Top 10 Holdings %
Top 10 Hldgs %
16.17%
Holding
798
New
72
Increased
310
Reduced
286
Closed
45
Top Buys
| 1 |
Amgen
AMGN
|
+$28M |
| 2 |
Meta Platforms (Facebook)
META
|
+$25.9M |
| 3 |
Southwest Airlines
LUV
|
+$18.5M |
| 4 |
Travelers Companies
TRV
|
+$17.6M |
| 5 |
Cigna
CI
|
+$16.9M |
Top Sells
| 1 |
Biogen
BIIB
|
+$75.9M |
| 2 |
Johnson & Johnson
JNJ
|
+$27.9M |
| 3 |
Gilead Sciences
GILD
|
+$25M |
| 4 |
Neurocrine Biosciences
NBIX
|
+$22.7M |
| 5 |
Amazon
AMZN
|
+$21.4M |
Sector Composition
| 1 | Healthcare | 22.62% |
| 2 | Technology | 14.66% |
| 3 | Financials | 14.55% |
| 4 | Consumer Discretionary | 9.89% |
| 5 | Communication Services | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDRX
376
DELISTED
Veradigm Inc. Common Stock
MDRX
| $2.84M | 0.05% |
195,000
+60,000
| +44% | +$873K |
|
377
Sherwin-Williams
SHW
$90.1B
| $2.83M | 0.05% |
20,724
+1,131
| +6% | +$155K |
|
378
Tapestry
TPR
$21.9B
| $2.78M | 0.05% |
62,868
-44,092
| -41% | -$1.95M |
|
|
S
379
DELISTED
Sprint Corporation
S
| $2.76M | 0.05% |
469,105
+8,647
| +2% | +$50.9K |
|
380
Halozyme
HALO
$8.9B
| $2.76M | 0.05% |
136,000
-23,000
| -14% | -$466K |
|
381
TC Energy
TRP
$53.9B
| $2.72M | 0.05% |
55,760
+14,084
| +34% | +$688K |
|
382
Brookfield
BN
$99B
| $2.7M | 0.05% |
115,374
+2,626
| +2% | +$61.4K |
|
383
Canadian Natural Resources
CNQ
$64.3B
| $2.68M | 0.05% |
152,858
+30,199
| +25% | +$530K |
|
384
Sun Life Financial
SLF
$32.9B
| $2.68M | 0.05% |
64,788
+757
| +1% | +$31.3K |
|
|
ATVI
385
DELISTED
Activision Blizzard Inc.
ATVI
| $2.68M | 0.05% |
42,359
+1,854
| +5% | +$117K |
|
386
Public Storage
PSA
$50.9B
| $2.68M | 0.05% |
12,816
+856
| +7% | +$179K |
|
387
Equinix
EQIX
$76.3B
| $2.65M | 0.05% |
5,852
+287
| +5% | +$130K |
|
388
Lexicon Pharmaceuticals
LXRX
$411M
| $2.65M | 0.05% |
268,000
-25,000
| -9% | -$247K |
|
|
NFX
389
DELISTED
Newfield Exploration
NFX
| $2.63M | 0.05% |
+83,312
| New | +$2.63M |
|
|
RETA
390
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $2.61M | 0.05% |
92,000
+32,000
| +53% | +$906K |
|
391
Hartford Financial Services
HIG
$36.8B
| $2.6M | 0.05% |
46,226
-340,489
| -88% | -$19.2M |
|
392
Cencora
COR
$57.9B
| $2.59M | 0.04% |
28,191
-279
| -1% | -$25.6K |
|
393
Boston Scientific
BSX
$160B
| $2.58M | 0.04% |
103,853
-3,613
| -3% | -$89.6K |
|
394
Yum! Brands
YUM
$40.5B
| $2.55M | 0.04% |
31,301
-110
| -0.4% | -$8.98K |
|
395
Republic Services
RSG
$71.5B
| $2.55M | 0.04% |
37,689
+852
| +2% | +$57.6K |
|
396
Ross Stores
ROST
$48.7B
| $2.55M | 0.04% |
31,736
-220,285
| -87% | -$17.7M |
|
397
Apellis Pharmaceuticals
APLS
$3.39B
| $2.54M | 0.04% |
+117,000
| New | +$2.54M |
|
398
Keurig Dr Pepper
KDP
$37.5B
| $2.53M | 0.04% |
26,038
+2,363
| +10% | +$229K |
|
399
Amphenol
APH
$143B
| $2.52M | 0.04% |
114,964
+12,292
| +12% | +$270K |
|
400
Fidelity National Information Services
FIS
$35.9B
| $2.49M | 0.04% |
26,482
+1,893
| +8% | +$178K |
|